Application 220016
- Type
- ANDA
- Sponsor
- KLM LABS PVT
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | MESALAMINE | MESALAMINE | ENEMA;RECTAL | 4GM/60ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A220016-001 | MESALAMINE | MESALAMINE | 4GM/60ML | ENEMA / RECTAL | AB | 2026-03-31 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A220016-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A220016-001 | MESALAMINE | 4GM/60ML | ENEMA / RECTAL | AB | 2026-03-31 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A220016-001 | MESALAMINE | 4GM/60ML | ENEMA / RECTAL | AB | 2026-03-31 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A220016-001 | MESALAMINE | 4GM/60ML | ENEMA / RECTAL | AB | 2026-03-31 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220016-001 | MESALAMINE | 4GM/60ML | ENEMA / RECTAL | AB | 2026-03-31 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A220016-001 | AB | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A220016-001 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A220016-001 | AB | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220016-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MESALAMINE | MESALAMINE | Bryant Ranch Prepack | 063ca661-1b5c-4941-a5b9-5dd0fa46b3d0 | 2024-05-29 | Warnings, Adverse reactions | MESALAMINE MESALAMINE |
| Mesalamine | MESALAMINE | Amneal Pharmaceuticals LLC | 00f77203-3615-47e8-ae25-6e1cf8a2a00a | 2024-05-23 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | Bryant Ranch Prepack | c9b1ef9d-1d06-48e7-87d2-7985b99124a6 | 2024-05-01 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| mesalamine | MESALAMINE | Golden State Medical Supply, Inc. | 170657d1-1f32-f036-e063-6294a90a4ed4 | 2024-04-26 | Warnings, Adverse reactions | mesalamine MESALAMINE |
| MESALAMINE | MESALAMINE | Lannett Company Inc. | 29dbe417-15a9-4c4d-846b-81cabda7ac70 | 2024-02-29 | Warnings, Adverse reactions | MESALAMINE MESALAMINE |
| Mesalamine | MESALAMINE | Camber Pharmaceuticals, Inc. | efa9d039-ae1f-4cd6-98f2-e87a901dfaeb | 2024-02-26 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | Camber Pharmaceuticals, Inc. | 04ce2182-2e8c-4598-a269-550cfaddde6c | 2024-02-15 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | ANI Pharmaceuticals, Inc. | 3cf751f2-a0c9-45d7-8acb-2bc61db0e4ac | 2024-02-14 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | Aurobindo Pharma Limited | d6c0fc76-644e-4301-9672-f432061e3d37 | 2024-01-20 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| MESALAMINE | MESALAMINE | Alembic Pharmaceuticals Inc. | 87d3d62d-2dc3-4e6f-be33-cabbca12e8f7 | 2024-01-09 | Warnings, Adverse reactions | MESALAMINE MESALAMINE |
| mesalamine | MESALAMINE | Teva Pharmaceuticals USA, Inc. | 8d27a608-3ba1-4799-be38-c00fb08ce3ce | 2023-12-19 | Warnings, Adverse reactions | mesalamine MESALAMINE |
| Mesalamine Rectal | MESALAMINE | Amring Pharmaceuticals Inc. | 87de237c-febb-42ca-b2a4-b444396f8640 | 2023-12-15 | Warnings, Adverse reactions | MESALAMINE |
| Mesalamine | MESALAMINE | Sun Pharmaceutical Industries, Inc. | fd8b02de-7dfa-444d-a1f8-1436b578e0cb | 2023-12-01 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | Mylan Pharmaceuticals Inc. | c8b93ea3-0367-4605-b87f-06c3812ff3b7 | 2023-11-30 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | Zydus Pharmaceuticals USA Inc. | cd8493f7-91fd-4c2d-b3d7-c1301825586b | 2023-10-26 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| mesalamine | MESALAMINE | Zydus Pharmaceuticals USA Inc. | 533bfaf5-0add-4b49-a4f2-ddea2b83f65d | 2023-10-26 | Warnings, Adverse reactions | mesalamine MESALAMINE |
| MESALAMINE | MESALAMINE | Alembic Pharmaceuticals Limited | 4ef59b85-e5a5-479f-a1fe-e1cee4d87670 | 2022-11-07 | Warnings, Adverse reactions | MESALAMINE MESALAMINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.